(Total Views: 661)
Posted On: 03/15/2021 3:52:50 AM
Post# of 154977
If Cytodyn is not testing for PD-L1 expression in our cancer trials they should be. CCR5 blockade downregulates PD-L1 and it would be helpful to know how well leronlimab does it. If it does it sufficiently we beat out Keytruda's PD-1 inhibition just on that alone.
(8)
(1)
